Literature DB >> 20173741

Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.

Marcel W Coolen1, Clare Stirzaker, Jenny Z Song, Aaron L Statham, Zena Kassir, Carlos S Moreno, Andrew N Young, Vijay Varma, Terence P Speed, Mark Cowley, Paul Lacaze, Warren Kaplan, Mark D Robinson, Susan J Clark.   

Abstract

Silencing of individual genes can occur by genetic and epigenetic processes during carcinogenesis, but the underlying mechanisms remain unclear. By creating an integrated prostate cancer epigenome map using tiling arrays, we show that contiguous regions of gene suppression commonly occur through long-range epigenetic silencing (LRES). We identified 47 LRES regions in prostate cancer, typically spanning about 2 Mb and harbouring approximately 12 genes, with a prevalence of tumour suppressor and miRNA genes. Our data reveal that LRES is associated with regional histone deacetylation combined with subdomains of different epigenetic remodelling patterns, which include re-enforcement, gain or exchange of repressive histone, and DNA methylation marks. The transcriptional and epigenetic state of genes in normal prostate epithelial and human embryonic stem cells can play a critical part in defining the mode of cancer-associated epigenetic remodelling. We propose that consolidation or effective reduction of the cancer genome commonly occurs in domains through a combination of LRES and LOH or genomic deletion, resulting in reduced transcriptional plasticity within these regions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173741      PMCID: PMC3058354          DOI: 10.1038/ncb2023

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  68 in total

1.  H3K27me3 forms BLOCs over silent genes and intergenic regions and specifies a histone banding pattern on a mouse autosomal chromosome.

Authors:  Florian M Pauler; Mathew A Sloane; Ru Huang; Kakkad Regha; Martha V Koerner; Ido Tamir; Andreas Sommer; Andras Aszodi; Thomas Jenuwein; Denise P Barlow
Journal:  Genome Res       Date:  2008-12-01       Impact factor: 9.043

2.  Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line.

Authors:  Einav Nili Gal-Yam; Gerda Egger; Leo Iniguez; Heather Holster; Steingrímur Einarsson; Xinmin Zhang; Joy C Lin; Gangning Liang; Peter A Jones; Amos Tanay
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205

3.  Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions.

Authors:  Lars Guelen; Ludo Pagie; Emilie Brasset; Wouter Meuleman; Marius B Faza; Wendy Talhout; Bert H Eussen; Annelies de Klein; Lodewyk Wessels; Wouter de Laat; Bas van Steensel
Journal:  Nature       Date:  2008-05-07       Impact factor: 49.962

4.  A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse.

Authors:  Gunnar Schotta; Roopsha Sengupta; Stefan Kubicek; Stephen Malin; Monika Kauer; Elsa Callén; Arkady Celeste; Michaela Pagani; Susanne Opravil; Inti A De La Rosa-Velazquez; Alexsandra Espejo; Mark T Bedford; André Nussenzweig; Meinrad Busslinger; Thomas Jenuwein
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

5.  Agglomerative epigenetic aberrations are a common event in human breast cancer.

Authors:  Petr Novak; Taylor Jensen; Marc M Oshiro; George S Watts; Christina J Kim; Bernard W Futscher
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

6.  Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.

Authors:  Sooryanarayana Varambally; Qi Cao; Ram-Shankar Mani; Sunita Shankar; Xiaosong Wang; Bushra Ateeq; Bharathi Laxman; Xuhong Cao; Xiaojun Jing; Kalpana Ramnarayanan; J Chad Brenner; Jindan Yu; Jung H Kim; Bo Han; Patrick Tan; Chandan Kumar-Sinha; Robert J Lonigro; Nallasivam Palanisamy; Christopher A Maher; Arul M Chinnaiyan
Journal:  Science       Date:  2008-11-13       Impact factor: 47.728

7.  Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells.

Authors:  Bo Wen; Hao Wu; Yoichi Shinkai; Rafael A Irizarry; Andrew P Feinberg
Journal:  Nat Genet       Date:  2009-01-18       Impact factor: 38.330

8.  Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.

Authors:  Xi-Song Ke; Yi Qu; Kari Rostad; Wen-Cheng Li; Biaoyang Lin; Ole Johan Halvorsen; Svein A Haukaas; Inge Jonassen; Kjell Petersen; Naomi Goldfinger; Varda Rotter; Lars A Akslen; Anne M Oyan; Karl-Henning Kalland
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

9.  Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island.

Authors:  Heather M O'Hagan; Helai P Mohammad; Stephen B Baylin
Journal:  PLoS Genet       Date:  2008-08-15       Impact factor: 5.917

10.  A polycomb group protein, PHF1, is involved in the response to DNA double-strand breaks in human cell.

Authors:  Zehui Hong; Jie Jiang; Li Lan; Satoshi Nakajima; Shin-ichiro Kanno; Haruhiko Koseki; Akira Yasui
Journal:  Nucleic Acids Res       Date:  2008-04-01       Impact factor: 16.971

View more
  87 in total

1.  Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines.

Authors:  Erika da Costa Prando; Luciane Regina Cavalli; Cláudia Aparecida Rainho
Journal:  Epigenetics       Date:  2011-12       Impact factor: 4.528

Review 2.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

3.  Evaluation of affinity-based genome-wide DNA methylation data: effects of CpG density, amplification bias, and copy number variation.

Authors:  Mark D Robinson; Clare Stirzaker; Aaron L Statham; Marcel W Coolen; Jenny Z Song; Shalima S Nair; Dario Strbenac; Terence P Speed; Susan J Clark
Journal:  Genome Res       Date:  2010-11-02       Impact factor: 9.043

Review 4.  Charting histone modifications and the functional organization of mammalian genomes.

Authors:  Vicky W Zhou; Alon Goren; Bradley E Bernstein
Journal:  Nat Rev Genet       Date:  2010-11-30       Impact factor: 53.242

Review 5.  STRIPAK complexes in cell signaling and cancer.

Authors:  Z Shi; S Jiao; Z Zhou
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

Review 6.  The epigenetics of epithelial-mesenchymal plasticity in cancer.

Authors:  Wai Leong Tam; Robert A Weinberg
Journal:  Nat Med       Date:  2013-11-07       Impact factor: 53.440

7.  Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma.

Authors:  Sarah Leonard; Wenbin Wei; Jennifer Anderton; Martina Vockerodt; Martin Rowe; Paul G Murray; Ciaran B Woodman
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

8.  Epigenetic abnormalities in cancer find a "home on the range".

Authors:  Hariharan Easwaran; Stephen B Baylin
Journal:  Cancer Cell       Date:  2013-01-14       Impact factor: 31.743

9.  Repitools: an R package for the analysis of enrichment-based epigenomic data.

Authors:  Aaron L Statham; Dario Strbenac; Marcel W Coolen; Clare Stirzaker; Susan J Clark; Mark D Robinson
Journal:  Bioinformatics       Date:  2010-05-10       Impact factor: 6.937

10.  Genome-wide DNA methylation maps in follicular lymphoma cells determined by methylation-enriched bisulfite sequencing.

Authors:  Jeong-Hyeon Choi; Yajun Li; Juyuan Guo; Lirong Pei; Tibor A Rauch; Robin S Kramer; Simone L Macmil; Graham B Wiley; Lynda B Bennett; Jennifer L Schnabel; Kristen H Taylor; Sun Kim; Dong Xu; Arun Sreekumar; Gerd P Pfeifer; Bruce A Roe; Charles W Caldwell; Kapil N Bhalla; Huidong Shi
Journal:  PLoS One       Date:  2010-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.